https://www.cochrane.org/zh-hant/evidence/CD000480_vinpocetine-acute-ischaemic-stroke
Vinpocetine for acute ischaemic stroke | Cochrane
acute ischaemic strokevinpocetinecochrane
https://www.nice.org.uk/guidance/ta264/chapter/2-The-technology
2 The technology | Alteplase for treating acute ischaemic stroke | Guidance | NICE
Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults
acute ischaemic strokethe technologyalteplase
https://www.cochrane.org/evidence/CD000029_oral-antiplatelet-therapy-acute-ischaemic-stroke
Oral antiplatelet therapy for acute ischaemic stroke | Cochrane
acute ischaemic strokeoraltherapycochrane
https://www.longdom.org/open-access/acute-ischaemic-stroke-treated-with-intravenous-thrombolysis-in-a-patient-with-a-known-large-brainstem-cavernous-malform-48962.html
Acute Ischaemic Stroke Treated with Intravenous Thrombolysis in a
Longdom Publishing SL is one of the leading international open access journals publishers, covering clinical, medical, and technology-oriented subjects
acute ischaemic stroketreatedintravenousthrombolysis
https://www.nice.org.uk/guidance/ta264/history
History | Alteplase for treating acute ischaemic stroke | Guidance | NICE
Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults
acute ischaemic strokehistoryalteplasetreatingguidance
https://www.cochrane.org/zh-hans/evidence/CD003242_anticoagulants-versus-antiplatelet-agents-acute-ischaemic-stroke
Anticoagulants versus antiplatelet agents for acute ischaemic stroke | Cochrane
acute ischaemic strokeantiplatelet agentsanticoagulantsversuscochrane
https://www.cochrane.org/evidence/CD002087_tirilazad-acute-ischaemic-stroke
Tirilazad for acute ischaemic stroke | Cochrane
acute ischaemic strokecochrane
https://www.cochrane.org/hr/evidence/CD003435_surgical-decompression-cerebral-oedema-acute-ischaemic-stroke
Surgical decompression for cerebral oedema in acute ischaemic stroke | Cochrane
acute ischaemic strokesurgicaldecompressioncerebraloedema
https://pmc.ncbi.nlm.nih.gov/articles/PMC3721925/
Management of ischaemic stroke in the acute setting: review of the current status - PMC
Acute ischaemic stroke can be treated by clot busting and clot removal. Thrombolysis using intravenous recombinant-tissue plasminogen activator (IV r-TPA) is...
ischaemic strokein the
https://www.cochrane.org/ru/evidence/CD004955_puerarin-acute-ischaemic-stroke
Puerarin for acute ischaemic stroke | Cochrane
acute ischaemic strokecochrane
https://www.cochrane.org/evidence/CD000064_corticosteroids-acute-ischaemic-stroke
Corticosteroids for acute ischaemic stroke | Cochrane
acute ischaemic strokecorticosteroidscochrane
https://www.gov.uk/government/publications/alteplase-for-treatment-of-acute-ischaemic-stroke-independent-review
Alteplase for treatment of acute ischaemic stroke: independent review - GOV.UK
The review of alteplase in the treatment of acute ischaemic stroke by the expert working group of the Commission on Human Medicines.
acute ischaemic strokeindependent reviewalteplasetreatment
https://www.nice.org.uk/guidance/ta264/resources
Tools and resources | Alteplase for treating acute ischaemic stroke | Guidance | NICE
Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults
tools and resourcesacute ischaemic strokealteplase
https://www.santepubliquefrance.fr/maladies-cardiovasculaires-et-accident-vasculaire-cerebral/accident-vasculaire-cerebral/article/effectiveness-antihypertensive-drugs-secondary-prevention-ischaemic-stroke-a-nationwide-historic
Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide...
antihypertensive drugssecondary preventionischaemic strokeeffectiveness
https://www.cochrane.org/ru/evidence/CD000211_theophylline-aminophylline-caffeine-and-analogues-acute-ischaemic-stroke
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke | Cochrane
acute ischaemic stroketheophyllineaminophyllinecaffeinecochrane
https://pmc.ncbi.nlm.nih.gov/articles/PMC8370080/
European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack - PMC
The aim of the present European Stroke Organisation Transient Ischaemic Attack (TIA) management guideline document is to provide clinically useful...
https://www.nice.org.uk/guidance/ta264/chapter/8-Sources-of-evidence-considered-by-the-Committee
8 Sources of evidence considered by the Committee | Alteplase for treating acute ischaemic stroke |...
Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults
https://www.nice.org.uk/guidance/ta264/chapter/4-Consideration-of-the-evidence
4 Consideration of the evidence | Alteplase for treating acute ischaemic stroke | Guidance | NICE
Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults
https://pmc.ncbi.nlm.nih.gov/articles/PMC7377582/
The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a...
To investigate the associations between major foods and dietary fibre with subtypes of stroke in a large prospective cohort. We analysed data on 418 329 men...
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2016/05/12/22/30/SOCRATES
Acute Stroke or Transient Ischaemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes...
Dharam J. Kumbhani, MD, SM, FACC
https://www.sciencemediacentre.org/expert-reaction-to-study-looking-at-covid-19-ischaemic-stroke-and-blood-clots/
expert reaction to study looking at COVID-19, ischaemic stroke and blood clots | Science Media...
https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.663899/full
Frontiers | Prediction of Clinical Outcomes in Acute Ischaemic Stroke Patients: A Comparative Study
Clinical stroke rehabilitation decision-making relies on multi-modal data, including imaging and other clinical assessments. However, most previously describ...
acute ischaemic stroke
https://www.mja.com.au/journal/2004/180/3/tissue-plasminogen-activator-tpa-acute-ischaemic-stroke-why-so-much-has-been-0
Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so...
Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little
https://www.elan-trial.ch/
ELAN Trial | Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke...
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1533674/full
Frontiers | New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke...
Background and purposeThe objective of this study is to systematically review the efficacy and safety of cilostazol-based dual antiplatelet therapy (DAPT) in...
new optionsfrontierscilostazol
https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2012/01/25/16/35/Evaluation-of-Risk-Stratification-Schemes-for-Ischaemic-Stroke
Evaluation of Risk Stratification Schemes for Ischaemic Stroke and Bleeding in 182,678 Patients...
https://hku.hk/press/news_detail_27315.html
HKUMed study finds good clinical outcomes for over 30% of ischaemic stroke patients receiving...
HKUMed research team finds that over 30% of ischaemic stroke patients who received intra-arterial mechanical thrombectomy had a good clinical outcome even...
https://openreview.net/forum?id=SyeOMoR4q4
Significance of Residual Learning and Boundary Weighted Loss in Ischaemic Stroke Lesion...
Residual learning with adversarial training and boundary weighted loss function results in significant boost in performance of ischaemic stroke segmentation.
https://www.rug.nl/about-ug/latest-news/news/archief2013/promoties-oraties/promotie-dhr.-m.m.h.-lahr_-organisational-models-for-thrombolysis-in-acute-ischaemic-stroke.-a-s
PhD ceremony Mr. M.M.H. Lahr: Organisational models for thrombolysis in acute ischaemic stroke. A...
Sep 14, 2021 - PhD ceremony: Mr. M.M.H. Lahr Dissertation: Organisational models for thrombolysis in acute ischaemic stroke. A simulation exemplar Promotor(s): prof. E...
https://scirp.org/journal/paperinformation?paperid=113585
Serum Ferritin and D-Dimer as Possible Risk Factors in Ischaemic Stroke in Cancer Patients
Discover the impact of cancer on ischemic stroke with this study comparing serum ferritin and d-dimer levels. Findings reveal a significant rise in...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10472963/
Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020 - PMC
We assessed best available data on access and delivery of acute stroke unit (SU) care, intravenous thrombolysis (IVT) and endovascular treatment (EVT) in the...
https://www.elsevier.es/en-revista-neurologia-english-edition--495-articulo-use-emergency-medical-transport-impact-S2173580818301664
Use of emergency medical transport and impact on time to care in patients with ischaemic stroke |...
IntroductionAccording to numerous studies, using emergency medical services (EMS) to
https://www.mdpi.com/1660-4601/19/21/13848
Life and Leisure Activities following Stroke or Transient Ischaemic Attack (TIA): An Observational,...
Objective: To examine changes in leisure participation following stroke/transient ischaemic attack (TIA) and explore its relationship to modifiable and...
life and leisure